XML 88 R61.htm IDEA: XBRL DOCUMENT v3.25.1
Non-Controlling Interests - Spero Gyrase - Additional Information (Detail) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Noncontrolling Interest [Line Items]    
Common stock issued, aggregate fair value   $ 221
Research and development expense $ 96,757 $ 51,440